Sunshine Biopharma (SBFM) Insider Trading & Ownership $1.46 -0.03 (-2.01%) Closing price 03:56 PM EasternExtended Trading$1.47 +0.01 (+0.62%) As of 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sunshine Biopharma (NASDAQ:SBFM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.10%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$32.80KNumber OfInsiders Selling(Last 3 Years)0 Get SBFM Insider Trade Alerts Want to know when executives and insiders are buying or selling Sunshine Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SBFM Insider Buying and Selling by Quarter Sunshine Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/4/2024Steve N SlilatyCEOBuy1,000$10.00$10,000.00 11/30/2022Camille SebaalyCFOBuy300$76.00$22,800.00 (Data available from 1/1/2013 forward) SBFM Insider Trading Activity - Frequently Asked Questions Who is on Sunshine Biopharma's Insider Roster? The list of insiders at Sunshine Biopharma includes Camille Sebaaly, and Steve N Slilaty. Learn more on insiders at SBFM. What percentage of Sunshine Biopharma stock is owned by insiders? 0.10% of Sunshine Biopharma stock is owned by insiders. Learn more on SBFM's insider holdings. Which Sunshine Biopharma insiders have been buying company stock? The following insider purchased SBFM shares in the last 24 months: Steve N Slilaty ($10,000.00). How much insider buying is happening at Sunshine Biopharma? Insiders have purchased a total of 1,000 SBFM shares in the last 24 months for a total of $10,000.00 bought. Sunshine Biopharma Key ExecutivesDr. Steve N. Slilaty Ph.D. (Age 72)CEO, President & Chairman Compensation: $640kMr. Camille Sebaaly (Age 65)CFO & Secretary Compensation: $695kDr. Abderrazzak Merzouki (Age 60)Chief Science Officer & Director Compensation: $340kMr. Marc Beaudoin (Age 57)Chief Operating Officer Mr. Malek Chamoun (Age 39)Chief Development Officer Mr. Robert G. Ferreira (Age 62)President of Sunshine Bio Investments Inc More Insider Trading Tools from MarketBeat Related Companies DYAI Insider Trading MIRA Insider Trading FBLG Insider Trading CVKD Insider Trading CING Insider Trading RVPH Insider Trading CASI Insider Trading QTTB Insider Trading PMN Insider Trading ADAP Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried? This page (NASDAQ:SBFM) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access